Huckleberry

Huckleberry (Vaccinium membranaceum and Related Species): A Comprehensive Reference

1. Identity: Botanical Classification, Species, and Common Forms

1.1 Taxonomic Identity and the Naming Problem

"Huckleberry" is a name used in North America for several plants in the family Ericaceae, in two closely related genera: Vaccinium and Gaylussacia. This taxonomic ambiguity is central to understanding the ingredient in dietary-supplement and functional-food contexts. The name "huckleberry" is a North American variation of the English dialectal name variously called "hurtleberry" or "whortleberry" for the bilberry. In North America, the name was applied to numerous plant variations, all bearing small berries with colors that may be red, blue, or black.

Huckleberry is a common name applied to several species of small to medium-sized shrubs in the heath family (Ericaceae), primarily in the genera Gaylussacia and Vaccinium, distinguished by their urn- or bell-shaped flowers and production of small, round, edible berries that range from red to dark purple or black. These berries typically contain multiple large seeds in Gaylussacia species (true huckleberries) and fewer, smaller seeds in Vaccinium species (often regionally termed huckleberries despite their closer relation to blueberries).

The Vaccinium genus is taxonomically complex; hybridization and polyploidy make delineation of species notoriously difficult. More than 35 species of blueberries (Vaccinium L.) and huckleberries (Vaccinium and Gaylussacia Kunth) are indigenous to North America.

1.2 Primary Species

The following are the species most commonly designated "huckleberry" in botanical, dietary, and commercial contexts:

• Vaccinium membranaceum Douglas ex Torr. — Known by the common names thinleaf huckleberry, tall huckleberry, big huckleberry, mountain huckleberry, square-twig blueberry, and ambiguously as "black huckleberry"; a species of flowering plant in the heath family Ericaceae. Scientific reviews focusing on the huckleberry in a pharmacological context primarily address this species, V. membranaceum. The huckleberry is the state fruit of both Idaho and Montana.
• Vaccinium ovatum Pursh — Known by the common names evergreen huckleberry, winter huckleberry, and California huckleberry.
• Vaccinium parvifolium Sm. — The red huckleberry, a species of Vaccinium native to western North America; a deciduous shrub growing to 4 metres tall with bright green shoots with an angular cross-section.
• Gaylussacia baccata (Wangenh.) K. Koch — The black huckleberry, considered by some botanists to represent the "true" huckleberry. The primary difference between Gaylussacia baccata and V. membranaceum lies in the seeds: V. membranaceum has tiny, almost unnoticeable seeds, while G. baccata's seeds are larger and more noticeable when eating the berries. Their habitats also vary: V. membranaceum is more commonly found in the western United States, while G. baccata is an eastern species.

The name is the common name for various Gaylussacia species, and some Vaccinium species, such as Vaccinium parvifolium, the red huckleberry, and is also applied to other Vaccinium species which may also be called blueberries depending upon local custom, as in New England and parts of Appalachia.

In the European herbal tradition, Vaccinium myrtillus (bilberry) is also known as European blueberry, whortleberry, huckleberry, and blaeberry. This terminological overlap means that a substantial proportion of clinical and pharmacological literature published under the name "huckleberry" in European contexts actually refers to bilberry (V. myrtillus), and any evaluation of the evidence must account for this distinction.

1.3 Botanical Description

Huckleberries are ericaceous (Ericaceae or Heath family) tetraploid (2n = 48) shrubs with fleshy, anthocyanin-rich, edible berries. Specifically, Vaccinium membranaceum is an erect shrub growing up to 1.5 metres in maximum height. The deciduous leaves are alternately arranged; the very thin to membranous, oval leaf blades are up to 5 centimetres long, with serrated edges, each tiny tooth tipped with a glandular hair. The mature fruit ranges from red through bluish-purple to a dark, almost black berry about 1 cm wide.

Vaccinium membranaceum grows at higher elevations in subalpine and alpine environments; it occurs in both pine- and spruce-dominated forests and in open meadow ecosystems, and in forests it often dominates the forest understory during early to mid stages of succession. Huckleberries require acidic and, usually but not imperatively, moist soils to become established, with V. membranaceum being known for its particular difficulty in establishment.

1.4 Common Preparations and Commercial Forms

Huckleberries can be eaten fresh or dried or prepared as a tea or jelly. As a dietary supplement or functional food ingredient, huckleberry is encountered in several forms:

• Fresh and frozen whole berry — consumed as food or used in culinary applications.
• Dried berry — huckleberries were often dried over a slow fire, creating a raisin-like product that could be kept indefinitely.
• Juice and juice concentrate — used in beverages and as a delivery vehicle in some clinical studies with related Vaccinium species.
• Standardized extracts — typical bilberry/huckleberry products sold in the supplement market are standardized to 25% anthocyanoside content.
• Leaf preparations (tea and infusion) — Vaccinium species fruits were an important traditional food for many Native American peoples, and leaves were used to make beverages.
• Tincture — hydroalcoholic extracts of the berry or leaf, used in Western herbal practice.

As a crop plant, huckleberry is not currently grown on a large commercial agriculture scale, despite efforts to make this possible. Wild-harvested berries from the Pacific Northwest and Rocky Mountain states therefore remain the dominant commercial source.

---

2. Traditional and Historical Use

2.1 Indigenous North American Use

The human usage of huckleberries may extend as far back as 11,000 B.P. (Before Present). The indigenous North American peoples recognized the quality of these edible fruits and revered these plants; beyond food needs, these plants played significant roles in their culture, sociology, economics, and spirituality. Because these traditions were developed and gathered over millennia and transmitted orally, documentation of their uses has been determined through archaeological data, written records from Western civilization after first contact, and recent surveys of present-day native peoples.

The most important berry crop for most of the Plateau peoples of Washington, Idaho, and Montana was the huckleberry (Vaccinium membranaceum), a type of blueberry, collected in August and September for winter consumption. Native peoples from several tribes came to the Indian Heaven area (now within the Gifford Pinchot National Forest, Washington) each summer to collect and process huckleberries, drying quantities of the fruit for over-winter storage and use. Among the groups that used the area were the Klickitat, Yakama, Wishram, Skinpah, and Kamiltpah (now part of the Yakama Nation), the Wyam from Celilo Falls, and the Cascades people from the Columbia River Gorge.

The Indians of the Plateau traveled to huckleberry sites where they gathered and dried the berries. Women usually did the gathering and could gather one or two basketfuls in a day's work (about 2–4 liters). Huckleberries were often dried over a slow fire set in a rotten log, creating a raisin-like product that could be kept indefinitely; they were also sun-dried.

The importance of huckleberries to the Indian nations of the Plateau region can be seen in the sacred rituals traditionally associated with the gathering of this berry, including a first-fruits ceremony in which the first berries collected were blessed and sung over. Huckleberries played significant parts in traditional legends, and harvest gathering times were causes of celebration and opportunities to visit friends and relatives not seen since the previous season.

Indigenous peoples of North America — including the Bear River Band, Karok, and Pomo tribes — found the plant and its fruit very useful; the bright red, acidic berries were used extensively for food throughout the year. Huckleberries were traditionally collected by Native American and First Nations people along the Pacific coast, interior British Columbia, Idaho, and Montana for use as food or traditional medicine.

The use and preservation of huckleberries is recorded as far back as 1615, when explorer Samuel de Champlain observed Native Americans collecting and drying huckleberries for winter use. In the Journals of Lewis and Clark, they wrote of the tribes west of the Rocky Mountains using dried berries extensively in 1805 and 1806.

2.2 Medicinal Uses in Traditional Practice

Some Native peoples made an infusion of roots and stems for heart problems or as an anti-rheumatic. The Tulalip tribe ate huckleberries at home and in ceremonies, brewed tea from the leaves, and used the juice to dye their clothes.

In the European herbal tradition, closely related species — particularly Vaccinium myrtillus (bilberry), which shares the common name "huckleberry" in some contexts — have a well-documented history of medicinal use. Fruits and leaves of V. myrtillus and V. vitis-idaea have been traditionally used as a remedy for coughs and fever, for the treatment of renal stones, intestinal and liver disorders, and diabetes, and for their astringent, tonic, and antiseptic properties. Leaves and fruits of V. arctostaphylos are known for their anti-hypertensive and anti-diabetic properties, and the fruits of V. corymbosum have been used as natural therapy for diabetes, inflammation, and gastrointestinal disorders.

---

3. Key Constituents and Active Compounds

3.1 Anthocyanins

Two huckleberry species, Vaccinium membranaceum and Vaccinium ovatum, native to Pacific Northwestern North America, have been evaluated for their total and individual anthocyanin and polyphenolic compositions. Each species contained 15 anthocyanins — galactoside, glucoside, and arabinoside of delphinidin, cyanidin, petunidin, peonidin, and malvidin — but in different proportions.

Analysis of V. membranaceum yielded a total monomeric anthocyanin content of 167 mg of cyanidin 3-glucoside per 100 g of frozen berries and a phenolic content of 617 mg of gallic acid per 100 g of frozen berries. A further 2004 study by Lee et al., which analysed fresh huckleberry fruits, found total monomeric anthocyanin content in a range of 101 to 360 mg/100 g and a content of total phenolics ranging from 367 to 1286 mg/100 g.

Prior to berry ripening, proanthocyanidins, flavonols, and hydroxycinnamic acids are the major phenolic compounds; during the ripening process, flavonoid profiles vary and anthocyanins accumulate in the skin. High levels and a wide variety of anthocyanins provide the red, blue, and purple colors that characterize berries of this genus.

3.2 Polyphenols and Other Phenolics

The major polyphenolics in V. membranaceum were neochlorogenic acid (3-O-caffeoylquinic acid, accounting for 26% of the total peak area measured at 320 nm) and a cinnamic acid derivative (21% of the total peak area). Minor polyphenolics identified in the ethyl acetate fraction included protocatechuic acid, gallic acid, and epicatechin.

The polyphenolics of both V. membranaceum and V. ovatum were mainly composed of cinnamic acid derivatives and flavonol glycosides. The major polyphenolic compound in V. membranaceum was neochlorogenic acid, and in V. ovatum, chlorogenic acid.

3.3 Macronutrients and Minerals

The first nutritional report of V. membranaceum dates from Kuhlein's analysis of fresh berries in 1989. For 100 g, this fruit quantified moisture content of 86%, 0.6% protein, 0.5% fat, 13.1% carbohydrates, 2% fibre, and 54 kcal. For minerals per 100 g: 14 mg Ca, 17 mg P, 0.4 mg Na, 8 mg Mg, 0.2 mg Fe, 0.1 mg Zn, 0.1 mg Cu, 2.5 mg Mn, and 0.3 mg Sr.

3.4 Other Notable Compounds

Mountain huckleberry is rich in aroma and flavor chemicals. Anthocyanins and polyphenolics are secondary plant metabolites comprising a varied group, with over 4,000 flavonoids having been described; these compounds are essential to food quality through taste, appearance, and health benefits. The fruits also contain tannins, pectin, and various flavonoid glycosides including arbutin (also found in closely related bilberry), as well as potassium and vitamin C.

3.5 Proposed Mechanisms of Action

Reports show that whole berry consumption usually confers positive effects on human health, and the health-promoting potentials are likely due to the presence of polyphenols with antioxidant activities. Among these polyphenols, various Vaccinium berry species have been reported to contain anthocyanins and flavonoids; these two polyphenolic compounds are known to have higher antioxidant activity and are beneficial for human health.

Inflammation is recognized as the first line of defense in animals in response to the attack of pathogens, allergens, or any kind of tissue injury. As a result of the inflammatory response, macrophages release inflammatory mediators such as interleukins, nitric oxide (NO), tumour necrosis factor-α (TNF-α), and prostaglandin (PGE2); overexpression of such mediators is associated with a response to type II diabetes, cancer, and cardiovascular diseases. Anthocyanins and related polyphenols are proposed to modulate these inflammatory pathways, providing a mechanistic rationale for observed biological effects.

Atherosclerosis, the main underlying factor in cardiovascular disease, is an inflammatory process associated with oxidative processes in and damage to the vascular endothelium; the anti-inflammatory and antioxidant effects of anthocyanins are of relevance to potential cardioprotective effects of huckleberry and related bilberry species.

---

4. Scientific Evidence by Area of Use

Critical methodological note: The overwhelming majority of clinical trial evidence examining the health effects of "huckleberry" compounds has been conducted with closely related Vaccinium species — principally V. myrtillus (bilberry) and V. angustifolium (wild blueberry) — rather than with V. membranaceum itself. The most comprehensive pharmacological review specifically covering huckleberry focuses on the distribution, history, bioactive compounds, and health-related effects of cranberry, blueberry, and huckleberry together as a genus. Where evidence is cited below, the specific species studied is identified. Evidence directly from V. membranaceum clinical trials is essentially absent at the time of writing; the phytochemical similarity to bilberry makes cross-species extrapolation a common but scientifically uncertain practice.

4.1 Antioxidant Activity

Vaccinium ovatum had greater total anthocyanin (ACY), total phenolics (TP), oxygen radical absorbing capacity (ORAC), and ferric reducing antioxidant potential (FRAP) than did V. membranaceum in a comparative laboratory assay published in the Journal of Agricultural and Food Chemistry (2004). Berry extracts from each species were separated into three fractions — anthocyanin, polyphenolic, and sugar/acids — by solid-phase extraction; the anthocyanin fractions of each species had the highest amount of ACY, TP, and antioxidant activity.

Vaccinium berries have a well-deserved reputation as potential healthy products and functional foods, supported by many studies which have identified and quantified various bioactive phytochemicals with known benefits for human health. However, in vitro antioxidant measurements (ORAC, FRAP, DPPH assays) are not directly translatable to in vivo effects in humans. Which components are responsible for the health benefits in humans is still unclear.

Evidence strength: For V. membranaceum specifically, antioxidant evidence is restricted to in vitro chemical assays. Human bioavailability and in vivo antioxidant effects have not been established in published clinical trials for this specific species.

4.2 Cardiovascular Health and Lipid Metabolism

The beneficial effects of anthocyanin consumption on cardiovascular risk are supported by mechanistic and epidemiologic evidence; a meta-analysis of 16 randomized controlled trials (RCTs) with 1,109 subjects explored the effects of Vaccinium berries rich in anthocyanins on serum lipids. The whortleberry (bilberry) group was significantly superior to placebo in lipid improvement; bilberry groups showed significant differences in reducing LDL-C and increasing HDL-C in comparison with other treatments. For many other subgroups and comparison arms, there was insufficient evidence to draw conclusions about efficacy.

Dietary intake of Vaccinium berries has demonstrated significant potential in preventing many risk factors associated with metabolic syndromes in the human population; in recent years, a multitude of research has shown the role of antioxidants derived from Vaccinium berries on chronic diseases such as cardiovascular disorders, diabetes, obesity, and cancer. Several studies have also investigated the effect of Vaccinium berry consumption on their ability to modulate the risk factors associated with oxidative stress, vascular function, inflammation, and lipid metabolism.

A 2025 meta-analysis published in Phytotherapy Research evaluated bilberry (V. myrtillus) supplementation on cardiometabolic indices. Cardio-metabolic health, crucial for preventing cardiovascular disease and type 2 diabetes, may benefit from bilberry's antioxidant and anti-inflammatory properties; the meta-analysis reviewed studies on bilberry's impact on lipid profiles, glycemic indices, body composition, and inflammatory and oxidative factors, with inclusion criteria of RCTs assessing bilberry supplementation in adults for at least one week.

Evidence strength: Moderate-quality evidence exists for bilberry (V. myrtillus) and wild blueberry (V. angustifolium) on lipid and cardiovascular parameters from multiple RCTs and a meta-analysis. Evidence for V. membranaceum (mountain huckleberry) specifically on cardiovascular outcomes is absent from the published clinical literature.

4.3 Anti-Inflammatory Effects

Supplementation with Medox — a commercial product of purified anthocyanins from bilberries supplying 300 mg of anthocyanins — by healthy subjects for 3 weeks was associated with a decrease in several NF-κB-regulated proinflammatory chemokines and immunoregulatory cytokines; a follow-up study showed decreased levels of hsCRP and inflammatory cytokines in plasma of 31 subjects who took 330 mL/day of bilberry juice for 4 weeks. Oxidative stress may mediate inflammation injury, and the antioxidant properties of bilberry may be responsible for at least some of the anti-inflammatory effects reported.

A randomized, double-blind, placebo-controlled clinical trial investigated Vaccinium arctostaphylos L. (Caucasian Whortleberry) — a species with anthocyanin-rich fruits — evaluating effects of its fruit extract on serum levels of IL-6, TNF-α, ICAM-1, and VCAM-1 in hyperlipidemic adult patients to assess its potential protective effect against atherosclerosis. This represents the type of direct human trial methodology applicable to the huckleberry genus, but was conducted with a different species.

Evidence strength: Preliminary to moderate for the Vaccinium genus broadly; small RCTs with bilberry support anti-inflammatory biomarker reduction. No clinical trials specific to V. membranaceum anti-inflammatory outcomes are available.

4.4 Glycemic Control and Metabolic Syndrome

Dietary intake of Vaccinium berries has demonstrated significant potential in preventing many risk factors associated with metabolic syndromes in the human population. In recent years, research has shown the role of antioxidants derived from Vaccinium berries on chronic diseases such as cardiovascular disorders, diabetes, obesity, and cancer; several studies have investigated the effect of Vaccinium berry consumption on their ability to modulate risk factors associated with oxidative stress, vascular function, inflammation, and lipid metabolism.

A study on postprandial healthy women showed that the administration of either whole lingonberries or extracts reduced sucrose-induced postprandial glucose and insulin concentrations throughout the first 30 minutes of consumption. During the second-hour post-intake, the concentration declined slowly but improved the overall glycemic profile (p < 0.05). Additionally, the investigation showed that whole berries and extracts stopped the sucrose-induced late postprandial hypoglycemic response and the compensatory free fatty acid recovery.

Clinical studies with bilberry and related species are limited; interest has focused on antioxidant potential in cancer and cardiovascular conditions, and other applications may exist in diabetes as well as in inflammatory bowel and ocular conditions.

Evidence strength: Evidence for glycemic benefits is preliminary and almost entirely from related Vaccinium species in small human studies. No published RCTs specifically test V. membranaceum huckleberry for glycemic outcomes.

4.5 Neuroprotection and Cognitive Function

There is much evidence supporting that oxidative stress of reactive oxygen species (ROS) in cells is responsible for the progression of neurodegenerative diseases such as Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and Alzheimer's disease; berry antioxidants also demonstrate neuroprotective activities, and several studies have shown that phenolic components from the Vaccinium species have anti-inflammatory and neuroprotective effects.

There are now several studies and human clinical trials documenting the beneficial effects of Vaccinium berries, and these findings suggest that they may be promising for preventing and treating neurodegenerative diseases; research focuses primarily on dietary Vaccinium berry consumption effects on human health and their potential role as therapeutic agents.

Evidence strength: Neuroprotection evidence for the Vaccinium genus is largely preclinical (cell culture, rodent models). Human trials with blueberry extract in aging populations show some cognitive benefits, but these are not specifically attributable to huckleberry (V. membranaceum).

4.6 Anti-Cancer Properties

Regarding cancer, studies showed that the consumption of berries reduces inflammation, inhibits angiogenesis, protects against DNA damage within the cell, and controls apoptosis and proliferation rates in malignant tumours; however, which components are responsible for the health benefits is still unclear.

Every year an increasing number of studies on Vaccinium extracts in cell lines and in vivo are being published; the majority are related to the assessment of anticancer properties and their activity in cancer cell lines.

Evidence strength: Anticancer evidence for huckleberry is limited to in vitro cell-line studies and animal models. No human clinical trials exist demonstrating anticancer effects for V. membranaceum or direct huckleberry preparations. Extrapolation from in vitro data to human cancer outcomes is not scientifically justified at this stage.

4.7 Ocular Health

There is sufficient evidence from animal and cell-culture studies and small human trials to warrant more powerful, controlled human trials of bilberry in helping to address the huge clinical problem of age- and diabetes-related vision loss. This assessment, from an NCBI Bookshelf chapter on bilberry (V. myrtillus), reflects the level of evidence for the closely related species most often conflated with huckleberry in the European literature.

Evidence strength: Small human trials with bilberry extracts suggest possible benefits for certain ocular conditions; however, these data apply to V. myrtillus specifically, and the evidence base is considered insufficient to support definitive health claims for any huckleberry species. The NCBI source explicitly calls for larger, controlled trials.

4.8 Antimicrobial Activity

Several studies highlight that the consumption of Vaccinium spp. presents numerous beneficial health-related outcomes, including antimicrobial effects, in addition to antioxidant, anti-inflammatory, and protective effects against diabetes, obesity, cancer, neurodegenerative diseases, and cardiovascular disorders. Antimicrobial activity in the Vaccinium genus has been attributed primarily to polyphenols, tannins, and organic acids. For huckleberry specifically, antimicrobial evidence remains at the in vitro level.

Evidence strength: In vitro only. No human clinical trials on huckleberry for infectious disease indications are available in the peer-reviewed literature.

---

5. Body Systems and Health Areas of Association

Based on the available phytochemical and preclinical literature, huckleberry and closely related Vaccinium species are associated with effects on the following body systems. Evidence quality varies substantially across systems as described above.

• Cardiovascular system: Modulation of lipid profiles (LDL-C, HDL-C), vascular inflammation, and endothelial function — primarily through anthocyanin-mediated antioxidant and anti-inflammatory mechanisms.
• Metabolic/endocrine system: Glycemic regulation, postprandial glucose and insulin response, potential anti-diabetic activity — chiefly from preclinical and small human studies with related species.
• Immune and inflammatory system: Downregulation of pro-inflammatory cytokines (TNF-α, IL-6, NF-κB pathway mediators) observed with bilberry anthocyanins in small human trials.
• Nervous system: Neuroprotection against oxidative stress-mediated neurodegeneration — evidence is preclinical and from related blueberry/bilberry species.
• Ocular system: Support for retinal microcirculation and vision — supported by small human trials with bilberry (V. myrtillus), not directly demonstrated with V. membranaceum.
• Gastrointestinal system: Traditional use as an astringent for diarrhea; preclinical evidence for gut microbiome modulation with Vaccinium polyphenols.
• Oncological (experimental): In vitro and animal evidence for anti-proliferative and pro-apoptotic effects in cancer cell lines; no human clinical trial evidence for huckleberry-specific preparations.

---

6. Dosage Forms and Reported Dosages

Because no clinical trials have been conducted exclusively with Vaccinium membranaceum (mountain huckleberry), the dosage data available in authoritative sources apply to closely related species, primarily bilberry (V. myrtillus), and to the broader Vaccinium genus. These are reported here as found in those sources, with species identified.

• Bilberry (V. myrtillus) fruit/standardized extract: Typical bilberry products are standardized to 25% anthocyanoside content, and 100 g of fresh fruit contains anthocyanin content of 300 to 700 mg. Limited clinical studies have evaluated supplemental bilberry 100 to 500 g over 1 to 8 weeks' duration; separately noted, limited clinical studies have evaluated daily supplemental bilberry 100 to 400 g over 4 to 8 weeks' duration.
• Bilberry juice: A follow-up study used 330 mL/day of bilberry juice for 4 weeks in 31 subjects, showing decreased levels of hsCRP and inflammatory cytokines in plasma.
• Purified anthocyanin supplement (Medox, from bilberry): 300 mg of anthocyanins administered to healthy subjects for 3 weeks was associated with a decrease in several NF-κB-regulated proinflammatory chemokines and immunoregulatory cytokines.

Storage and processing of the fresh berries leads to degradation of anthocyanin content, and variations in bioavailability have been observed. This is a significant practical consideration when comparing fresh berry consumption to processed or standardized extract dosage forms.

---

7. Safety Considerations and Interactions

7.1 General Safety Profile

Bilberry and related huckleberry species are generally recognized as safe (GRAS) when used as food. Doses above those found in food should be avoided because safety and efficacy are unproven. Contraindications have not yet been identified. GRAS status applies when used as food.

7.2 Antiplatelet and Anticoagulant Interactions

Agents with antiplatelet properties, including herbs with anticoagulant/antiplatelet properties, may enhance the adverse/toxic effect of antiplatelet agents; bleeding may occur, and consideration of therapy modification is warranted. This interaction risk extends to anticoagulant drug classes. High flavonoid intake from bilberry/huckleberry supplements could theoretically increase the risk of bleeding when taken with blood-thinning drugs like warfarin, NSAIDs, and aspirin, or when taken by people with bleeding disorders.

7.3 Dose-Dependent Gastrointestinal Effects

While moderate amounts of huckleberries have traditionally been used to address diarrhea due to their astringent tannin content, large quantities of the berry act as a laxative, consistent with the dose-dependent behavior of many tannin- and fiber-rich foods. This bidirectional effect on bowel function is noted in herbal reference sources.

7.4 Potential Drug Interactions

Doses above food levels should be avoided because safety and efficacy are unproven. Herbs with anticoagulant/antiplatelet properties may enhance the adverse/toxic effect of agents with antiplatelet properties. Theoretically, due to the anthocyanin and flavonoid content, interactions with cytochrome P450 enzyme substrates are plausible, as has been documented for other polyphenol-rich berries, but specific data for V. membranaceum are not available in the peer-reviewed clinical literature.

7.5 Pregnancy and Lactation

No clinical data on the safety of supplemental huckleberry doses during pregnancy or lactation are available in authoritative sources. Food-level consumption has a long history of safe use across many populations, but therapeutic-dose supplementation has not been evaluated in these populations.

7.6 Allergic Reactions

Allergic reactions are possible in individuals with known sensitivity to other Ericaceae family members. Cross-reactivity with other berry species should be considered in atopic individuals, though documented cases specifically attributable to huckleberry are not reported in the clinical literature reviewed.

---

8. Status of Commercialization and Research Limitations

As a crop plant (along with the other huckleberries of the genus in western North America), Vaccinium parvifolium and V. membranaceum are not currently grown on a large commercial agriculture scale, despite efforts to make this possible. V. membranaceum is known for its particular difficulty in establishment under cultivation, making standardized commercial supply from cultivated sources largely unavailable.

This supply constraint has significant implications for supplement research and regulation: the relative scarcity of the ingredient compared to bilberry or cultivated blueberry means that dedicated clinical trials with standardized V. membranaceum preparations are essentially absent. Traditional uses of Vaccinium-based preparations have been supported by modern research, and for many Vaccinium components — such as polyphenols, anthocyanins, and flavonoids — important biological functions have been described in scientific literature. However, whether these findings can be directly applied to wild-harvested V. membranaceum as a discrete dietary ingredient requires further species-specific investigation.

The Vaccinium genus is taxonomically complex, and hybridization and polyploidy make delineation of species notoriously difficult. This complicates the interpretation of "huckleberry" in supplement labeling, as products sold under this name may contain any of several species, or be derived from processing of bilberry or wild blueberry with the "huckleberry" label applied for marketing purposes.

---

References

• Wikipedia — Huckleberry
• Wikipedia — Vaccinium membranaceum
• Wikipedia — Vaccinium parvifolium
• Vaccinium Species (Ericaceae): Phytochemistry and Biological Properties of Medicinal Plants — PMC / Molecules (2023)
• Vaccinium Species (Ericaceae): Phytochemistry and Biological Properties of Medicinal Plants — MDPI Molecules (2023)
• Effects of Vaccinium-derived antioxidants on human health: the past, present and future — PMC / Frontiers in Molecular Biosciences (2024)
• Effects of Vaccinium-derived antioxidants on human health: the past, present and future — Frontiers in Molecular Biosciences (2024)
• Comparison of Anthocyanin Pigment and Other Phenolic Compounds of Vaccinium membranaceum and Vaccinium ovatum — Journal of Agricultural and Food Chemistry (2004)
• Compounds of Vaccinium membranaceum and V. ovatum — USDA ARS (2004)
• Effects of Vaccinium Berries on Serum Lipids: A Meta-Analysis of Randomized Controlled Trials — PMC (2015)
• Evaluation of the effect of Vaccinium arctostaphylos fruit extract on serum inflammatory biomarkers in adult hyperlipidemic patients: a randomized double-blind placebo-controlled clinical trial — PMC
• Effect of Dietary Berry Supplementation on Antioxidant Biomarkers in Adults with Cardiometabolic Risks: A Systematic Review of Clinical Trials — PMC
• Vaccinium Species — Unexplored Sources of Active Constituents for Cosmeceuticals — PMC
• Bilberry (Vaccinium myrtillus L.) — Herbal Medicine — NCBI Bookshelf
• Bilberry Uses, Benefits & Dosage — Drugs.com Natural Products Database
• Investigating the Effects of Vaccinium myrtillus Supplementation on Cardiometabolic Indices: A Systematic Review and Meta-Analysis — Phytotherapy Research (2025)
• Effects of Vaccinium berries on oxidative stress, inflammation, exercise performance, and recovery — a systematic review — Food & Function (RSC, 2024)
• Manna in Winter: Indigenous Americans, Huckleberries, and Blueberries — HortScience (2013)
• Manna in Winter: Indigenous Americans, Huckleberries, and Blueberries — Purdue University / HortScience PDF (2013)
• Northwest Tribes: Traditional Huckleberry Harvest — USDA Forest Service, Gifford Pinchot National Forest
• Species: Vaccinium membranaceum — USDA Forest Service Fire Effects Information System
• Thinleaf Huckleberry (Vaccinium membranaceum) — U.S. Fish & Wildlife Service
• Blueberries and Huckleberries — Oregon Encyclopedia (Oregon Historical Society)
• Gaylussacia baccata (black huckleberry) — Go Botany, Native Plant Trust
• Mountain Huckleberry, Vaccinium membranaceum — Native Plants PNW
• Vaccinium Species (Ericaceae): From Chemical Composition to Bio-Functional Activities — MDPI Applied Sciences (2021)